Premium
Retracted: Long‐term efficacy and safety of blonanserin in patients with first‐episode schizophrenia: A 1‐year open‐label trial
Author(s) -
Ninomiya Yuriko,
Miyamoto Seiya,
Tenjin Tomomi,
Ogino Shin,
Miyake Nobumi,
Kaneda Yasuhiro,
Sumiyoshi Tomiki,
Yamaguchi Noboru
Publication year - 2014
Publication title -
psychiatry and clinical neurosciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.609
H-Index - 74
eISSN - 1440-1819
pISSN - 1323-1316
DOI - 10.1111/pcn.12202
Subject(s) - clinical trial , schizophrenia (object oriented programming) , psychiatry , term (time) , medicine , informed consent , family medicine , psychology , alternative medicine , pathology , physics , quantum mechanics
The above article from Psychiatry and Clinical Neurosciences, first published on 6 July 2014 in Wiley Online Library ( www.onlinelibrary.wiley.com ), and in Volume 68, Issue 12 pp. 841–849, has been retracted by agreement between the authors, the Editors‐in‐Chief, Shigenobu Kanba and Tadafumi Kato, and John Wiley & Sons Australia Ltd. The retraction has been agreed following a report from the Investigation Committee of Clinical Trials carried out at St. Marianna University School of Medicine which established that the trial included subjects who did not satisfy inclusion criteria due to a number of factors, including lack of written informed consent. At the same time, the Committee verified that there was no falsification, fabrication or other infringement associated with the paper.